On November 10, Google started rolling out its November Pixel Drop, a free update for Pixel phones and watches. A key change: Gemini Intelligence now comes to the Pixel 10.
That brings Rambler, which turns your spoken thoughts into tidy text without the “ums”, plus helpful suggestions before you ask, and help with multi-step tasks like ordering groceries or booking a ride.
Why it matters: your phone is starting to do small jobs for you, not just answer questions. And last year’s phones get these features through an update.
You can also ask your phone to build a custom widget, like a monthly spending tracker or a holiday countdown. On the Pixel 11, Gemini now screens unknown callers in a more natural conversation.
Can you use it? If you have a Pixel 10 or newer, the update arrives over the coming weeks. Some features are limited to certain countries and languages.
On November 10, Spotify gave its AI DJ seven new English voices and two new Spanish voices, with British, American, Irish, Australian and Indian accents.
The DJ plays music picked for your taste and talks between songs. Now you can also switch off that chatter, so the music keeps playing with fewer interruptions.
Spotify says 80% of DJ listeners come back to it week after week.
Why it matters: AI that talks to you is becoming normal. Letting people pick the voice, or turn it off, gives them more control over how it feels.
Can you use it today? Yes, if you have Spotify Premium in a country where the DJ is available, including Norway.
AlphaGenome 2. Image: Google DeepMind. Image source
On November 11, Google DeepMind released AlphaGenome 2, an AI model that predicts how small changes in our DNA affect specific types of cells, like heart or immune cells.
Every cell carries the same DNA, but each type uses it differently. The model learned from more than 100 million individual cells across 68 tissues, and finds nearly twice as many important DNA changes as earlier models.
The important limit: it is a research tool only. It is not approved for diagnosing or treating patients, and its predictions still need to be tested in the lab.
Why it matters: many diseases start with tiny DNA changes in specific cells. Finding them faster could speed up research into new treatments.